drugset

drugset / Trial / NCT00575003

Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

NCT00575003 ↗

Phase 2 Completed 64 enrolled Cytos Biotechnology AG

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to test the efficacy of a vaccine against house dust mite and/or cat allergy compared to placebo in adult patients.

Timeline

Start: 2007-12
Primary completion: 2009-03
Completion: 2009-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CYT003-QbG10	Vaccine	—	Subcutaneous

Indications